Last, we propose neurosin as a potential marker of synucleinopathy and a natural candidate in studies elucidating whether a specific panel of CSF proteins will aid the identification, discrimination and differential diagnosis of various synucleinopathies versus AD. This evidence concerns the gene KLK6 and Alzheimer disease.